Trial intelligence / Profile preview

Clarithromycin for Cachexia in NSCLC

NCT02416570Phase 2Terminated

Sponsor
University of Nottingham
Start
Apr 2015
Primary completion
Oct 2015
Modality
Small Molecules
01

Overview

A Phase 2 trial of clarithromycin in cachexia, sponsored by University of Nottingham. Started Apr 2015; status: terminated.

02

Drugs

clarithromycin
03

Conditions

cachexia

Beyond the preview

Go deeper on NCT02416570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02416570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call